Guillermo Javierre Villacampa

机构：Breast Cancer Research Foundation, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Solti, Vall d'Hebron Institute of Oncology · ORCID：0000-0003-4868-6585

发表论文 433 篇 · 总被引 4267 次 · h-index 33

代表论文

• Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO) (2026 · Nature Communications · 被引 2)
• Abstract PD10-01: Elacestrant alone or in combination with triptorelin in premenopausal women with ER+/HER2- early breast cancer: primary analysis from the phase 2 SOLTI-2104- PremiÈRe trial (2026 · Clinical Cancer Research · 被引 1)
• CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis (2026 · Bone Marrow Transplantation · 被引 1)
• Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysis (2026 · JHEP Reports · 被引 1)
• Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial (2026 · Carolina Digital Repository (University of North Carolina at Chapel Hill))
• Evolving landscape of targeted therapies in early phase clinical trials (2026 · European Journal of Cancer)